Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NUCLEAR: Blood Clearance Kinetics of Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer
NCT06929013Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- May 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Open-label trial (5 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Kinetic of nucleosome and CCCTC-binding factor (CTCF) at 14 days. Started May 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06929013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06929013.